These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 526409)

  • 1. Proceedings of the Second Symposium on Labetalol, London, March 1979.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-244S. PubMed ID: 526409
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the Third Symposium on Labetalol.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):1S-141S. PubMed ID: 7093091
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A
    Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
    Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV
    Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576
    [No Abstract]   [Full Text] [Related]  

  • 7. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 10. [Labetalol--ergometric and polycardiographic studies].
    Dziekański S; Adamska-Dyniewska H; Słomka S; Tkaczewski W
    Wiad Lek; 1984 Mar; 37(5):334-41. PubMed ID: 6475046
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of labetalol and chlorthalidone on exercise tolerance in hypertensive subjects].
    Raffo M; Cherchi A; Sau F; Pirisi R; Seguro C; Pisano MR
    Boll Soc Ital Cardiol; 1979; 24(6):657-66. PubMed ID: 551798
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacological basis for the use of labetalol in the treatment of hypertension.
    Prichard BN; Richards DA
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S24-9. PubMed ID: 6169957
    [No Abstract]   [Full Text] [Related]  

  • 18. Labetalol in hypertension.
    Lancet; 1977 Apr; 1(8017):890-1. PubMed ID: 67294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.